Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Federico II University3,000 enrolled

Overview

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Type 2 Diabetes

Interventions

data collectionOTHER

Data collection on diabetes therapy and follow-up

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years; * Diagnosis of type 2 diabetes mellitus (T2DM); * Stable clinical conditions * Outpatient settings * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * Patients with type 1 diabetes mellitus; * Active participation in interventional studies; * Any condition that may put the patient at risk by participating in the study.

Outcomes

Primary Outcomes

Diabetes treatment adherence according to the most recent European Guidelines

Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.

Time frame: 12-24-36-48 months